Valuation: West Pharmaceutical Services, Inc.

Market Cap 25.38B 22.24B 20.64B 18.97B 35.75B 2,449B 36.27B 246B 96.26B 1,198B 95.27B 93.22B 4,140B P/E 2026 *
42.7x
P/E 2027 * 37.3x
Enterprise Value 24.87B 21.79B 20.23B 18.59B 35.03B 2,400B 35.55B 241B 94.33B 1,174B 93.36B 91.35B 4,057B EV / Sales 2026 *
7.46x
EV / Sales 2027 * 6.97x
Free-Float
93.54%
Yield 2026 *
0.24%
Yield 2027 * 0.27%
1 day+0.24%
1 week+0.96%
Current month+1.60%
1 month+14.96%
1 week 288.29
Extreme 288.287
294.02
1 month 269.97
Extreme 269.9675
294.02
Current year 253.33
Extreme 253.329
294.02
1 year 253.33
Extreme 253.329
294.02
3 years 253.33
Extreme 253.329
294.02
5 years 253.33
Extreme 253.329
294.02
10 years 253.33
Extreme 253.329
294.02
Manager TitleAgeSince
Chief Executive Officer 56 23/04/2015
Director of Finance/CFO 57 03/08/2025
Chief Tech/Sci/R&D Officer - 31/07/2025
Director TitleAgeSince
Director/Board Member 65 31/01/2011
Director/Board Member 69 06/03/2011
Director/Board Member 56 11/02/2012
Change 5-day change 1-year change 3-year change Capi.($)
+0.24%+0.96% - - 25.38B
+0.90%+12.66%-20.01%-12.26% 174B
-0.56%+1.76%-10.65%-7.74% 105B
-0.82%+1.35%+2.60%+57.00% 58.97B
-1.59%-2.05%+36.71%+59.47% 52.24B
-0.44%-1.11%-15.51%-45.29% 42.39B
-4.89%-5.73% - - 33.05B
-4.44%-1.79%-16.08%-44.07% 28.84B
-0.56%-0.42%-5.87%-9.30% 20.64B
-1.85%-1.52%-9.08%+0.50% 20.28B
Average -1.47%+2.39%-4.74%-0.21% 59.49B
Weighted average by Cap. -0.88%+5.00%-7.87%+0.30%

Financials

2026 *2027 *
Net sales 3.33B 2.92B 2.71B 2.49B 4.69B 322B 4.76B 32.29B 12.64B 157B 12.51B 12.24B 544B 3.54B 3.1B 2.88B 2.64B 4.98B 341B 5.06B 34.28B 13.42B 167B 13.28B 12.99B 577B
Net income 604M 529M 491M 452M 851M 58.3B 863M 5.85B 2.29B 28.53B 2.27B 2.22B 98.54B 686M 601M 558M 512M 966M 66.16B 980M 6.64B 2.6B 32.37B 2.57B 2.52B 112B
Net Debt -508M -445M -413M -380M -716M -49.03B -726M -4.92B -1.93B -23.99B -1.91B -1.87B -82.87B -741M -649M -603M -554M -1.04B -71.53B -1.06B -7.18B -2.81B -35B -2.78B -2.72B -121B
Logo West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. specializes in the design, manufacture and marketing of components and systems for the containment and delivery of injectable drugs. The group offers packaging, components for syringes, cartridge systems, auto-injection devices, accessories for vials, specialty components, etc. Net sales break down by family of products as follows: - proprietary products (80.7%); - - contract-manufactured products (19.3%). At the end of 2024, the group had 21 production sites worldwide. Net sales are distributed geographically as follows: the United States (42.5%), Germany (12.9%), Ireland (11.2%), France (8.4%), Europe (13.3%) and other (11.7%).
Employees
10,800
Date Price Change
21/07/26 CHF 291.24 +0.24%
21/07/26 CHF 290.53 +0.78%
20/07/26 CHF 288.29 -1.95%
17/07/26 CHF 294.02 +0.32%
16/07/26 CHF 293.09 +1.91%
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
359.24USD
Average target price
385.33USD
Spread / Average Target
+7.26%

Quarterly revenue - Rate of surprise